Your browser doesn't support javascript.
loading
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Aggarwal, Charu; Saba, Nabil F; Algazi, Alain; Sukari, Ammar; Seiwert, Tanguy Y; Haigentz, Missak; Porosnicu, Mercedes; Bonomi, Marcelo; Boyer, Jean; Esser, Mark T; Cheng, Lily I; Agrawal, Sonia; Jennings, Emily C; Durham, Nicholas M; Fraser, Karl; Lissa, Delphine; Gong, Maozhen; Ceaicovscaia, Natalia; Gascó Hernández, Amaya; Kumar, Rakesh.
Affiliation
  • Aggarwal C; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Saba NF; Winship Cancer Institute, Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • Algazi A; Department of Medicine: Hematology/Oncology, University of California, San Francisco, San Francisco, California.
  • Sukari A; Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.
  • Seiwert TY; Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
  • Haigentz M; Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey.
  • Porosnicu M; Wake Forest School of Medicine, Winston-Salem, North Carolina.
  • Bonomi M; Ohio State University, Columbus, Ohio.
  • Boyer J; Inovio Pharmaceuticals, Philadelphia, Pennsylvania.
  • Esser MT; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
  • Cheng LI; Pathology, Oncology Safety, AstraZeneca, Gaithersburg, Maryland.
  • Agrawal S; Oncology Data Science, Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, Maryland.
  • Jennings EC; Oncology Data Science, Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, Maryland.
  • Durham NM; Oncology R&D Translational Medicine, AstraZeneca, Gaithersburg, Maryland.
  • Fraser K; Oncology R&D, AstraZeneca, Gaithersburg, Maryland.
  • Lissa D; Early Oncology Clinical Science, AstraZeneca, Cambridge, United Kingdom.
  • Gong M; Oncology R&D, AstraZeneca, Gaithersburg, Maryland.
  • Ceaicovscaia N; Early Clinical Development, Oncology R&D, AstraZeneca, Gaithersburg, Maryland.
  • Gascó Hernández A; Late Development, R&D Oncology, AstraZeneca, Gaithersburg, Maryland.
  • Kumar R; Oncology R&D, AstraZeneca, Gaithersburg, Maryland.
Clin Cancer Res ; 29(3): 560-570, 2023 02 01.
Article in En | MEDLINE | ID: mdl-36455147
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomavirus Infections / Head and Neck Neoplasms Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomavirus Infections / Head and Neck Neoplasms Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: Estados Unidos